Search Results - "Bolchini, Marco"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    White Matter Hyperintensities Quantification in Healthy Adults: A Systematic Review and Meta‐Analysis by Melazzini, Luca, Vitali, Paolo, Olivieri, Emanuele, Bolchini, Marco, Zanardo, Moreno, Savoldi, Filippo, Di Leo, Giovanni, Griffanti, Ludovica, Baselli, Giuseppe, Sardanelli, Francesco, Codari, Marina

    Published in Journal of magnetic resonance imaging (01-06-2021)
    “…Background Although white matter hyperintensities (WMH) volumetric assessment is now customary in research studies, inconsistent WMH measures among homogenous…”
    Get full text
    Journal Article
  2. 2

    Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine by Ceccardi, Giulia, Schiano di Cola, Francesca, Caratozzolo, Salvatore, Di Pasquale, Michele, Bolchini, Marco, Padovani, Alessandro, Rao, Renata

    Published in Toxins (30-11-2023)
    “…The aim of the present study was to evaluate whether previous preventive treatment with onabotulinumtoxin-A might influence subsequent clinical response…”
    Get full text
    Journal Article
  3. 3

    Photophobia and migraine outcome during treatment with galcanezumab by Schiano di Cola, Francesca, Ceccardi, Giulia, Bolchini, Marco, Caratozzolo, Salvatore, Liberini, Paolo, Padovani, Alessandro, Rao, Renata

    Published in Frontiers in neurology (18-01-2023)
    “…Calcitonin gene-related peptide (CGRP) plays a pivotal role in migraine physiology, not only regarding migraine pain but also associated symptoms such as…”
    Get full text
    Journal Article
  4. 4

    Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine by di Cola, Francesca Schiano, Bolchini, Marco, Caratozzolo, Salvatore, Ceccardi, Giulia, Cortinovis, Matteo, Liberini, Paolo, Rao, Renata, Padovani, Alessandro

    Published in Neurology international (13-02-2023)
    “…The aim of the present study was to assess the migraine outcome, in particular migraine disability, in chronic (CM) and high frequency episodic migraine (HFEM)…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    An observational study on monoclonal antibodies against calcitonin‐gene‐related peptide and its receptor by Schiano di Cola, Francesca, Bolchini, Marco, Ceccardi, Giulia, Caratozzolo, Salvatore, Liberini, Paolo, Rao, Renata, Padovani, Alessandro

    Published in European journal of neurology (01-06-2023)
    “…Background and purpose Based on their pharmacological target, two classes of calcitonin‐gene‐related peptide (CGRP) monoclonal antibodies (mAbs) have been…”
    Get full text
    Journal Article
  8. 8

    Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab by Bolchini, Marco, Schiano di Cola, Francesca, Ceccardi, Giulia, Caratozzolo, Salvatore, Liberini, Paolo, Rao, Renata, Padovani, Alessandro

    Published in European neurology (01-03-2023)
    “…The aim of the present study was to assess erenumab efficacy in migraine disability and intensity throughout the first treatment cycle, discontinuation, and…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11